Biomarkers of acute kidney injury in pediatric cardiac surgery.
Candice Torres de Melo Bezerra CavalcanteMarcelo Borges CavalcanteKlebia Magalhães Pereira Castello BrancoTitus ChanIsabel Cristina Leite MaiaRonald Guedes PompeuAndrea Consuelo de Oliveira TellesAnna Karina Martins BritoAlexandre Braga LibórioPublished in: Pediatric nephrology (Berlin, Germany) (2021)
Acute kidney injury (AKI) is characterized by a sudden decrease in kidney function. Children with congenital heart disease are a special group at risk of developing AKI. We performed a systematic review of the literature to search for studies reporting the usefulness of novel urine, serum, and plasma biomarkers in the diagnosis and progression of AKI and their association with clinical outcomes in children undergoing pediatric cardiac surgery. In thirty studies, we analyzed the capacity to predict AKI and poor outcomes of five biomarkers: Cystatin C, Neutrophil gelatinase-associated lipocalin, Interleukin-18, Kidney injury molecule-1, and Liver fatty acid-binding protein. In conclusion, we suggest the need for further meta-analyses with the availability of additional studies.